Dr. Decker on Stereotactic Body Radiation Therapy in Lung Cancer
Roy Decker, MD, PhD
Roy Decker, MD, PhD, associate professor of Therapeutic Radiology, Yale Cancer Center, discusses stereotactic body radiation therapy (SBRT) as a treatment for patients with lung cancer.
Although SBRT has only been around for about 20 years, it is rapidly becoming a standard of care approach for patients with early-stage non–small cell lung cancer (NSCLC) who are not eligible for surgery, says Decker.
A number of attempts to initiate randomized trials comparing the efficacy of SBRT with surgery have failed, mainly due to poor accrual. Currently, a large consortium trial is underway comparing lobectomy with SBRT for patients with early-stage NSCLC who are at a borderline risk for surgery.